Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 26247417" data-attributes="member: 562115">The vaccine was developed by the Oxford University. It was one of several (I think 9 vaccines) supported by CEPI (Coalition for Epidemic Preparedness Innovations) - A global foundation set up around 2016. Then Astra-Zeneca was involved and Prof Sarah Gilbert (who is the lead developer) committed that it will be free (or at cost) as long as Covid is declared as a pandemic.Otherwise Prof Glibert with another colleague had their own company Vaccitech. Vaccitech was a small enterprise and thus Astra-Zeneca came into the picture as a major partner.  AstraZeneca paid the university an up-front fee of $10m (£7.4m) and has promised a further $80m (£59.4m) in "milestone payments".Astra-Zenaca made commercial agreements with other vaccine manufacturers around the world (ISI in India is just one)  So what dictates the manufacture and delivery are the terms in this agreeement.This is just a brief of the background - things are more complex than this - once the vaccine gets sold commercially (post pandemic) then even the Oxford Uni will get a share close to 50%.</blockquote>

Top Bottom